Goto

Collaborating Authors

Results


Artificial intelligence makes a splash in small-molecule drug discovery

#artificialintelligence

In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast datasets, more than 150 companies with a focus on AI have raised funding in this period, based on an analysis of the field by Back Bay Life Science Advisors (Figure 1a). And the number of financings and average amount raised soared in 2021. At the forefront of this field are companies harnessing AI approaches such as machine learning (ML) in small-molecule drug discovery, which account for the majority of financings backed by venture capital (VC) in recent years (Figure 1b), as well as some initial public offerings (IPOs) for pioneers in the area (Table 1). Such companies have also attracted large pharma companies to establish multiple high-value partnerships (Table 2), and the first AI-based small-molecule drug candidates are now in clinical trials (Nat.


4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare

#artificialintelligence

Some say that artificial intelligence (AI) will radically change healthcare in the future. But that prediction overlooks an important detail: AI is already significantly changing healthcare. IBM (NYSE:IBM) Watson Health general manager Deborah DiSanzo spoke at the annual J. P. Morgan Healthcare Conference on Wednesday. She provided an update on the progress that IBM Watson, the AI system famous for beating Jeopardy! DiSanzo highlighted four areas where AI is making a big difference today.


Industry News

#artificialintelligence

Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. Updates are provided on a monthly basis. Sign-Up for our newsletter and never miss out on the latest news and updates. As 2019 came to an end, Veritas Genetics struggled to get funding due to concerns it had previously taken money from China. It was forced to cease US operations and is in talks with potential buyers. The GenomeAsia 100K Project announced its pilot phase with hopes to tackle the underrepresentation of non-Europeans in human genetic studies and enable genetic discoveries across Asia. Veritas Genetics, the start-up that can sequence a human genome for less than $600, ceases US operations and is in talks with potential buyers Veritas Genetics ceases US operations but will continue Veritas Europe and Latin America. It had trouble raising funding due to previous China investments and is looking to be acquired. Illumina loses DNA sequencing patents The European Patent ...


4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare

#artificialintelligence

Some say that artificial intelligence (AI) will radically change healthcare in the future. But that prediction overlooks an important detail: AI is already significantly changing healthcare.


4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare

#artificialintelligence

Some say that artificial intelligence (AI) will radically change healthcare in the future. But that prediction overlooks an important detail: AI is already significantly changing healthcare.


4 Ways IBM Watson's Artificial Intelligence Is Changing Healthcare

#artificialintelligence

Some say that artificial intelligence (AI) will radically change healthcare in the future. But that prediction overlooks an important detail: AI is already significantly changing healthcare.